CTOs on the Move

Alivia Technology

www.aliviatechnology.com

 
We launched Absolute Insight in 2016 to empower business users in the healthcare sector, where our clients have used it to alleviate the opioid crisis, curb waste in the healthcare system, and target fraudulent entities. As an industry agnostic platform, we`ve began to expand our service across other verticals, fulfilling our mission to become the global gateway for business users to leverage advanced analytics and artificial intelligence at scale. With a deep understanding of your company`s pain points and a platform that makes advanced analytics truly easy, your business users can create data-driven actionable insights and automated pipelines. As data continues ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

MD Anderson Cancer Center

MD Anderson has built a worldwide reputation for excellence in cancer patient care, research, education and prevention. We couldn`t have done it without our top-notch faculty and staff, or the generous spirit of volunteers and community members who donate everything from free time to pints of blood to help us in our mission to end cancer. Our various departments work as a team to deliver multidisciplinary cancer care, a concept pioneered by MD Anderson.

Rexton

Rexton, Inc is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Murphy Medical Center

Murphy Medical Center is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Murphy Medical Center is based in Murphy, NC. You can find more information on Murphy Medical Center at www.murphymedical.org

Genetics and IVF Institute

Genetics and IVF Institute is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Genetics and IVF Institute is based in Fairfax, VA. You can find more information on Genetics and IVF Institute at www.givf.com

Symbiomix Therapeutics

Symbiomix (sim-bye-OH-mix) is a late-stage, privately held biopharmaceutical company developing innovative medicines for serious women`s health infections that have been long neglected and are in need of new therapeutic options. Symbiomix was founded in 2012 by a team of experienced industry professionals and entrepreneurs and is backed by three of the world`s leading healthcare venture capital firms, OrbiMed, Fidelity Biosciences and HBM Partners. The Company`s lead product is SYM-1219, a novel drug candidate containing secnidazole, which is a next generation 5-nitroimidazole antibiotic. Symbiomix is based in New Jersey, with additional offices in Maryland and Connecticut.